Aceso Life Science's (HKG:0474) attributable loss narrowed to HK$137 million in the half-year ended Sept. 30 from HK$207 million in the year-ago period, according to a Thursday filing with the Hong Kong Exchange.
Loss per share at the construction machinery company narrowed to HK$0.0191 from HK$0.0285 in the previous year.
Revenue declined to HK$109 million from HK$113 million a year earlier.